LEVI & KORSINSKY, LLP: FRAUD-ON-THE-MARKET DOCTRINE UNDERPINS ULTRAGENYX PHARMACEUTICAL SECURITIES CLASS ACTION
LEVI & KORSINSKY, LLP: FRAUD-ON-THE-MARKET DOCTRINE UNDERPINS ULTRAGENYX PHARMACEUTICAL SECURITIES CLASS ACTION |
| [18-March-2026] |
Know Your Rights: How Basic Inc. v. Levinson Enables Investor Recovery NEW YORK, March 18, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP announces that a securities class action has been filed against Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE).
YOU MAY BE AFFECTED IF YOU:
The Efficient Market Hypothesis In Basic Inc. v. Levinson, 485 U.S. 224 (1988), the Supreme Court recognized that in an efficient market, publicly available information is rapidly incorporated into stock prices. This means that when a company makes materially false or misleading statements, the artificial inflation caused by those statements is embedded in the stock price---even if individual investors did not directly read or hear the false statements. The action alleges that Ultragenyx's stock traded in such an efficient market during the Class Period. The Fraud-on-the-Market Doctrine
Learn more about your rights or contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com | (212) 363-7500. Application to Ultragenyx The action alleges that Ultragenyx common stock traded on the NASDAQ during the Class Period, a highly efficient and automated market. Plaintiffs contend that the Company communicated with investors through established market mechanisms, including SEC filings, press releases, and earnings calls, and that the stock was followed by securities analysts whose reports were publicly available. Rule 23 Class Certification Federal Rule of Civil Procedure 23 governs class certification requirements. The action alleges that common questions of law and fact predominate over individual issues, making class treatment superior to individual litigation. These common questions include whether defendants' statements were materially false or misleading and whether the stock price was artificially inflated. "Securities class actions allow investors to efficiently pursue claims that might otherwise be too costly to bring individually," said Joseph E. Levi, Esq. "The legal framework supports investor recovery when fraud is alleged." Join the Ultragenyx class action or call (212) 363-7500. ABOUT THE FIRM Levi & Korsinsky, LLP represents investors in securities class actions nationwide, with particular expertise in complex fraud-on-the-market cases and Section 10(b) litigation. The firm has been ranked among ISS Securities Class Action Services' Top 50 for seven consecutive years. Lead plaintiff applications must be submitted by April 6, 2026. CONTACT:
SOURCE Levi & Korsinsky, LLP | ||
Company Codes: NASDAQ-NMS:RARE |
View original content to download multimedia:
